Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers
NCT03836859
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
rhNGF 20μg/mL
OTHER:
Placebo
Sponsor
Dompé Farmaceutici S.p.A
Collaborators
[object Object]